On 18 December 2024, iFlyHealth (2506 HK, also known as Xunfei Healthcare) officially goes IPO on the Hong Kong Stock Exchange.

iFlyHealth is the AI-driven healthcare subsidiary of iFlytek (2230 SZ), a Chinese national champion of artificial intelligence that developed the Spark large language model, which rivals the capabilities of ChatGPT. After the IPO, iFlytek will continue to be the controlling shareholder of iFlyHealth.

Despite being sanctioned by the US since 2019, iFlytek and iFlyHealth has done remarkably well. iFlytek’s share price has vastly outperformed the Hang Seng Tech Index over the past five years.

This is excellent news for China Merchants China Direct Investments (CMCDI, 133 HK), which owns 3.4% stake in iFlyHealth (as at 30 September 2024). CMCDI also owns listed shares in iFlytek, as well as a 15% stake in a AI-and-internet-focused fund called iFlytek Venture Capital LLP.

These iFlytek-related investments account for 13% of CMCDI’s total assets as at 30 September 2024.

We hope that iFlyHealth’s share price will soar.

Chat with us on WeChat or WhatsApp:

💬 WeChat ID: ASM_Argyle

💬 WhatsApp ID: +852 6317 6371

🖥️ UnlockValueChinaMerchants.com

📧 ChinaMerchants@asmhk.com


2024年12月18日,讯飞医疗(2506 HK)正式发布招股说明书,即将登陆港交所。

讯飞医疗是科大讯飞(2230 SZ)旗下的人工智能驱动的医疗科技公司,科大讯飞是中国人工智能领域的先驱,开发了与ChatGPT相媲美的星火大模型(Spark)。在讯飞医疗首次公开募股之后,科大讯飞仍为其控股股东。

这对于招商局中国基金(133.HK,招商基金)来说是极大的好事。招商基金持有讯飞医疗3.4%的股份(截至2024年9月30日),同时持有科大讯飞的股票,并持有投资人工智能及互联网的安徽科訊創業投資基金合夥企業(有限合夥)约15%的权益。

科大讯飞及其相关公司的总投资占招商基金总资产的13%(截至2024年9月30日)。

希望讯飞医疗股票大涨!

欢迎随时跟我们联系:

💬 微信: ASM_Argyle

💬 WhatsApp: +852 6317 6371

🖥️ UnlockValueChinaMerchants.com

📧 ChinaMerchants@asmhk.com

Leave a comment